Fig. 4
From: Clinical and pathological staging of the cancer at the nanoscale
Percent of unlabeled (malignant) fraction of tumor cells U% vs. energy of the hypoxic cell EHypoxic:cell
Fig. 4 | Cancer Nanotechnology
From: Clinical and pathological staging of the cancer at the nanoscale
Percent of unlabeled (malignant) fraction of tumor cells U% vs. energy of the hypoxic cell EHypoxic:cell